Last reviewed · How we verify
NCT05289505: MUSIC-RT
Evaluation of Music on the Level of Anxiety Felt During External Radiotherapy Sessions
trial testing MUSIC-CARE in Radiotherapy Side Effect in 83 participants. Completed in 26 March 2023.
31 August 2022
Quick facts
| Lead sponsor | Center Eugene Marquis |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 83 |
| Start date | 18 January 2022 |
| Primary completion | 31 August 2022 |
| Estimated completion | 26 March 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- MUSIC-CARE
Conditions studied
- Radiotherapy Side Effect — all drugs for Radiotherapy Side Effect →
Sponsor
Center Eugene Marquis — full company profile →
Who can join
18 and older, any sex, with Radiotherapy Side Effect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective study with a historical comparator. Each of the prospective study endpoints will be compared to data collected retrospectively in patients treated with radiation therapy prior to the implementation of the MUSIC-CARE device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05289505
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Radiotherapy Side Effect
Currently open trials in the same condition.
- NCT06950073 — Curatively Intended Thoracic Reirradiation · recruiting
- NCT06311955 — Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor · Phase 2 · recruiting
- NCT07008716 — Omitting CTV for Primary Tumor in LS-SCLC · Phase 3 · recruiting
- NCT06758830 — Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. · Phase 2, PHASE3 · recruiting
- NCT06752239 — Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC · Phase 3 · recruiting
Other Center Eugene Marquis trials
Trials by the same sponsor.
- NCT07189598 — Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer · NA · recruiting
- NCT07122089 — Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis · Phase 2 · not yet recruiting
- NCT06551272 — Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma · Phase 2 · recruiting
- NCT06627075 — Optical Surface Guidance for External Radiotherapy of Head and Neck Cancer · NA · recruiting
- NCT06583460 — Systematic Intervention to Improve Sexual Dysfunction · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05289505 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Center Eugene Marquis
- Last refreshed: 4 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05289505.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing